Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Tokar

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Quantifying costs associated with atopic dermatitisCharles N Ellis, Mary M Prendergast, Michael Tokar, et al.
The Journal of Investigative Dermatology|August 12, 2004
Look beyond financial conflicts of interest in evaluating industry-academia collaborations in burden-of-illness and outcomes research studies in dermatologyMary M Prendergast, William Abramovits, Mark Boguniewicz, et al.
Pharmacoeconomics|June 18, 2005
The economics of topical immunomodulators for the treatment of atopic dermatitisWilliam Abramovits, Mark Boguniewicz, Amy S Paller, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Quantifying costs associated with atopic dermatitisCharles N Ellis, Mary M Prendergast, Michael Tokar, et al.
The Journal of Investigative Dermatology|August 12, 2004
Look beyond financial conflicts of interest in evaluating industry-academia collaborations in burden-of-illness and outcomes research studies in dermatologyMary M Prendergast, William Abramovits, Mark Boguniewicz, et al.
Pharmacoeconomics|June 18, 2005
The economics of topical immunomodulators for the treatment of atopic dermatitisWilliam Abramovits, Mark Boguniewicz, Amy S Paller, et al.
Pageof 1